Related Experiment Videos
Secondary cancers after a lung carcinoid primary: a population-based analysis
M L Cote1, A S Wenzlaff, P A Philip
1Population Studies and Prevention Program, Karmanos Cancer Institute, Wayne State University, Detroit, MI 48201, United States. cotem@med.wayne.edu
Lung Cancer (Amsterdam, Netherlands)
|March 29, 2006
Summary
Lung carcinoid tumors may increase the risk of secondary breast and prostate cancers, particularly within five years of diagnosis. Further research into genetics and hormonal factors is warranted.
Area of Science:
- Oncology
- Epidemiology
Background:
- Lung carcinoid tumors, first described in 1937, have an unclear etiology.
- Investigating secondary cancer risk after lung carcinoid diagnosis may offer etiological insights.
Observation:
- A population-based study analyzed 1882 lung carcinoid cases from the SEER Program (1988-2000).
- Standardized incidence ratios (SIR) were used to compare observed versus expected secondary cancer diagnoses.
Findings:
- An increased risk of secondary breast cancer was observed (SIR=1.80), primarily within five years post-diagnosis (SIR=1.68).
- A decreased risk of breast cancer was noted more than five years after diagnosis (SIR=0.29).
- Secondary prostate cancer risk was elevated (2.8 times expected), also concentrated within the first five years.
Implications:
- Findings suggest potential genetic or environmental (hormonally related) factors in lung carcinoid development.
- Further exploration of genetic and sex hormone roles, alongside other risk factors, is recommended.